CHD

Church & Dwight Co., Inc. - 10-Q Summary (Q3 2009)

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended September 25, 2009, and the nine-month period ended on that date. Church & Dwight Co., Inc. is a manufacturer of household and personal care products (Consumer Domestic and Consumer International segments) and specialty chemical products (Specialty Products Division). The company operates as a large accelerated filer.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 2.5% in Q3 and 4.1% for the nine months, driven by higher unit volumes (particularly in Consumer Domestic), price increases, and the Orajel acquisition. These gains were partially offset by unfavorable foreign exchange rates (-2.1% in Q3, -3.4% for 9 months) and divestitures.
• Profitability: Gross margins expanded significantly (430 bps in Q3) due to lower commodity costs, price increases, and cost reduction programs. Net income rose 43% in Q3 and 26% for the nine months.
• Unusual Items:
  • Patent Litigation Settlement: A $20.0 million gain (net of legal expenses) was recognized in Q3 2009 following a settlement with Abbott Laboratories regarding patent infringement.
  • Impairment Charges: A $4.0 million asset impairment charge was recorded in Q3 2009 at an international subsidiary due to currency-related competitive pressures.
  • Plant Shutdown: Accelerated depreciation charges of $13.5 million were recorded for the nine months related to the closure of the North Brunswick, NJ facility.
• Segment Performance:
  • Consumer Domestic: Sales up 8.3% (Q3) and 12.0% (9mo); Income before taxes up significantly due to volume, price, and the litigation gain.
  • Consumer International: Sales down 7.6% (Q3) and 13.4% (9mo) primarily due to foreign exchange headwinds and the Spain subsidiary divestiture.
  • Specialty Products: Sales down 17.6% (Q3) due to weak dairy markets and lower volumes.

Guidance, Outlook, and Risks

• Capital Expenditures: The company is constructing a new laundry detergent plant in York County, PA. Total project cost is estimated at $142 million. Approximately $68 million was spent in the first nine months of 2009, with an additional $23 million expected in the remainder of 2009.
• Dividends: The Board increased the quarterly dividend from $0.09 to $0.14 per share in July 2009.
• Liquidity: The company maintains strong liquidity with $419.2 million in cash and significant available credit ($85 million securitization facility, $96 million revolving credit). Management believes cash flow and borrowing capacity are sufficient to meet obligations.
• Risks:
  • Regulatory: Potential FDA labeling restrictions on nonoxynol-9 (N-9) in condoms could impact sales and incur costs for obsolete inventory.
  • Market: Economic conditions could affect consumer demand; foreign exchange fluctuations continue to impact international results.
  • Commodity: Volatility in raw material and energy prices (mitigated partially by hedging).

Investor Verification Checklist

• Litigation Settlement Timing: Verify the cash receipt of the $27 million Abbott settlement (paid Oct 2, 2009) and its impact on Q4 cash flow versus Q3 earnings recognition.
• York Plant Progress: Monitor the completion timeline and cost overruns for the new York County facility, which is expected to be fully operational by end of 2009.
• Foreign Exchange Sensitivity: Assess the ongoing impact of currency fluctuations on the Consumer International segment, which saw significant sales declines.
• North Brunswick Closure: Track the execution of the facility shutdown, including severance payments (majority due in 2010) and exit costs.
• Debt Covenants: Confirm continued compliance with leverage (1.7x) and interest coverage (12.7x) ratios under the primary credit facility.